[{"Assets_0_Q2_USD":10203000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":175000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":177000000.0,"StockholdersEquityConverted_0_Q2_USD":4481000000.0,"StockholdersEquity_0_Q2_USD":4481000000.0,"RevenuesConverted_2_Q2_USD":2242000000.0,"RevenuesConverted_1_Q2_USD":1217000000.0,"NetIncomeLossConverted_2_Q2_USD":190000000.0,"NetIncomeLossConverted_1_Q2_USD":97000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":232000000.0,"EarningsPerShareDiluted_2_Q2_USD":1.01,"EarningsPerShareDiluted_1_Q2_USD":0.52,"EarningsPerShareBasic_2_Q2_USD":1.02,"EarningsPerShareBasic_1_Q2_USD":0.53,"CommonStockSharesOutstanding_0_Q2_shares":171032640.0,"CommonStockSharesConverted_0_Q2_shares":171032640.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":175000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":173000000.0,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20211231","fy":"2022.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20220201"}]